Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: Comparison with prostatic adenocarcinoma and benign prostate

Modern Pathology

Volumn 11, Issue 3, 1998, Pages 247-252

  Tamboli, Pheroze ^a   Amin, Mahul B ^a   Xu, Hong Ji ^b   Linden, Michael D ^a  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Carcinoma; Immunohistochemistry; p53 gene; Prostate; Prostatic intraepithelial neoplasia; Retinoblastoma gene; Tumor suppressor genes

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; GENE EXPRESSION; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RETINOBLASTOMA PROTEIN; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031889640     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Amin MB, Ro JY, Ayala AG. Putative precursor lesions of prostatic adenocarcinoma: fact or fiction? Mod Pathol 1993; 6:476-83.
2. Weintraub SJ, Prater CA, Dean DC. Retinoblastoma protein switches the E2F site from positive to negative element. Nature 1992;358:259-61.
3. Ishikawa J, Xu HJ, Hu SX, Yandell DW, Maeda S, Kamidono KS, et al. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 1991;51:5736-43.
4. Venter DJ, Bevan KL, Ludwig RL, Riley TE, Jat PS, Thomas DG, et al. Retinoblastoma gene deletions in human glioblastomas. Oncogene 1991;6:445-8.
5. Batsakis JG, El-Naggar AK. p53: 15 years after discovery. Adv Anat Pathol 1995;2:71-88.
6. Stricker HJ, Jay J, Linden MD, Tamboli P, Amin MB. Determining progression of localized prostate carcinoma by immunohistochemical detection of mutant p53. Urology 1996; 47:366-9.
7. Drago JR, Mostofi FK, Lee F. Introductory remarks and workshop summary: workshop on prostatic intraepithelial neoplasia, significance and correlation with prostate-specific antigen and transrectal ultrasound. Urology 1989;34(Suppl): 2-3.
8. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol 1993;24:298-310.
9. Gown AM, de Waver N, Battifora H. Microwave-based antigen unmasking: a revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1993;1: 255-66.
10. Resnick JM, Cherwitz D, Knapp D, Uhlman D, Niehans G. A microwave method that enhances detection of aberrant p53 expression in formalin-fixed, paraffin-embedded tissues. Arch Pathol Lab Med 1995;119:360-6.
11. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986;17:64-71.
12. Bostwick DG, Brawer MK. Prostatic intraepithelial neoplasia and early invasion in prostate cancer. Cancer 1987;59:788-94.
13. Troncoso P, Babaian RJ, Ro JY, Grignon DJ, von Eshenbach AC, Ayala AG. Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. Urology 1989;34:52-6.
14. Epstein JI, Cho KR, Quinn BD. Relationship of severe dysplasia to stage A (incidental) adenocarcinoma of prostate. Cancer 1990;65:2321-7.
15. Tamboli P, Amin MB, Schultz DS, Linden MD, Kubus J. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Mod Pathol 1996;9:1015-9.
16. Amin MB, Schultz DS, Zarbo RJ, Kubus J, Shaheen C. Computerized static DNA ploidy analysis of prostatic intraepithelial neoplasia. Arch Pathol 1993;117:794-8.
17. Montironi R, Galluzi CM, Diamanti L, Giannulis I, Pisani E, Scarpelli M. Prostatic intraepithelial neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei. Virchows Arch A Pathol Anat Histopathol 1993;422:185-92.
18. Sakr WA, Sarkar FH, Sreepathi P, Drozdavicz S, Crissman JD. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF. Prostate 1993;22:147-54.
19. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 1993;143:390-400.
20. Perlman EJ, Epstein JI. Blood group antigen expression in dysplasia and adenocarcinoma of the prostate. Am J Surg Pathol 1990;14:810-8.
21. Maygarden SJ, Strom S, Ware JL. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med 1992;116: 269-73.
22. Amin MB, Ro JY, Ayala AG. Prostatic intraepithelial neoplasia: its relationship to prostate adenocarcinoma. In: Rosen PP, Fechner RE, editors. Pathology annual. Norfolk: Appleton Lange; 1994. p. 1-30.
23. Xu HJ, Cairns P, Hu SX, Knowles MA, Benedict WF. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int J Cancer 1993;53:781-4.
24. Reismann PT, Koga H, Takahashi R, Figlin RA, Holmes EC, Piantadosi S, et al. Inactivation of the retinoblastoma susceptibility gene in non-small cell lung cancer. Oncogene 1993;8:1913-9.
25. Geradts J, Hu SX, Lincoln CE, Benedict WF, Xu HJ. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int J Cancer 1994;58:161-7.
26. Phillips SM, Barton CM, Lee SJ, Morton DG, Wallace DM, Lemoine NR, et al. Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br J Cancer 1994;70:1252-7.
27. Tricoli JV, Gumerlock PH, Yao JL, Chi SG, D'Souza SA, Nestok BR, et al. Alterations of the retinoblastoma gene in human prostate adenocarcinoma. Genes Chromosom Cancer 1996;5:108-14.
28. Phillips SM, Morton DG, Lee SJ, Wallace DM, Neoptolemos JP. Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q, and 16q in human prostate cancer. Br J Urol 1994;73:390-5.
29. Sarkar FH, Sakr W, Li YW, Macoska J, Ball DE, Crissman JD. Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas. Prostate 1992;21:145-52.
30. Jacquemier J, Moles JP, Penault-Llorca F, Adelaide J, Torrente M, Viens P, et al. p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison staining and PCR-SSCP results. Br J Cancer 1994;69:846-52.
31. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 1993;20:1657-69.
32. Grignon DJ, Caplan R, Sarkar FH, Lawton CA, Hammond EH, Pilepich MV, et al. p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J Natl Cancer Inst 1997;89:158-65.
33. Myers RB, Oelschlager D, Srivastava S, Grizzle WE. Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas. Prostate 1994;25:243-8.
34. Lee S, Ro JY, Park K, Kwon K, Ayala AG. Expression of p53 in benign prostatic hyperplasia and prostate adenocarcinoma: an immunohistochemical study with correlation of PCNA expression [abstract]. Mod Pathol 1994;7:78A.
35. Humphrey PA, Swanson PE. Immunoreactive p53 protein in high-grade prostatic intraepithelial neoplasia. Pathol Res Pract 1995;191:881-7.
36. Mirchandani D, Zheng J, Miller GJ, Ghosh AK, Shibata DK, Cote RJ, et al. Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. Am J Pathol 1995; 147:92-101.
37. Qian J, Jenkins RB, Bostwick DG. Potential markers of aggressiveness in prostatic intraepithelial neoplasia detected by fluorescence in situ hybridization. Eur Urol 1996;30:177-84.
38. Shin HJC, Kalapurakal SK, Lee JJ, Ro JY, Hong WK, Lee JS. Comparison of p53 immunoreactivity in fresh-cut versus stored slides with and without microwave heating. Mod Pathol 1997;10:224-30.